Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Liabilities from Discontinued Operations (2019 - 2021)

Vycor Medical has reported Liabilities from Discontinued Operations over the past 3 years, most recently at 802.0 for Q1 2021.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 802.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was 802.0 through Mar 2021, changed N/A year-over-year, with the annual reading at 3605.0 for FY2020, 95.62% down from the prior year.
  • Liabilities from Discontinued Operations was 802.0 for Q1 2021 at Vycor Medical, down from 3605.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 82216.0 in Q4 2019 and troughed at 802.0 in Q1 2021.
  • The 3-year median for Liabilities from Discontinued Operations is 9884.0 (2020), against an average of 32634.8.
  • The largest YoY upside for Liabilities from Discontinued Operations was 95.62% in 2020 against a maximum downside of 95.62% in 2020.
  • A 3-year view of Liabilities from Discontinued Operations shows it stood at 82216.0 in 2019, then tumbled by 95.62% to 3605.0 in 2020, then plummeted by 77.75% to 802.0 in 2021.
  • Per Business Quant, the three most recent readings for VYCO's Liabilities from Discontinued Operations are 802.0 (Q1 2021), 3605.0 (Q4 2020), and 9884.0 (Q3 2020).